How do I buy Mirum Pharmaceuticals (MIRM) stock?

You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.View our list of the best stock brokerages

Who are Mirum Pharmaceuticals (MIRM) competitors?

Other companies in Mirum Pharmaceuticals’s space includes: Immunovant Inc (NASDAQ:IMVT), Legend Biotech Corp (NASDAQ:LEGN), Celcuity Inc (NASDAQ:CELC), Cogent Biosciences Inc (NASDAQ:COGT) and Alkermes PLC (NASDAQ:ALKS).

What is the forecast, or price target, for Mirum Pharmaceuticals (MIRM) stock?

Mirum Pharmaceuticals has a consensus price target of $82.83.

What is the current price for Mirum Pharmaceuticals (MIRM)?

The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $92.32 last updated January 15, 2026 at 4:00 PM EST.

Does Mirum Pharmaceuticals (MIRM) pay a dividend?

There are no upcoming dividends for Mirum Pharmaceuticals.

When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?

Mirum Pharmaceuticals does not have any upcoming earnings scheduled.

Is Mirum Pharmaceuticals (MIRM) going to split?

There is no upcoming split for Mirum Pharmaceuticals.

What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Mirum Pharmaceuticals (MIRM) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered,...

Comments